NEW YORK (GenomeWeb) – Premaitha Health said today that it has settled its patent dispute and signed a licensing and supply agreement with Illumina related to noninvasive prenatal testing technology.
Under the agreement, Manchester, UK-based Premaitha has licensed Illumina's NIPT patent pool, allowing it to offer testing in Europe and other countries covered by the intellectual property.